To further dissect the underlying molecule mechanism of pericyte‐IL32 mediated TKI sensitivity in cancer cells, we performed comparative proteomics analysis of HCC827 or PC9 cells after being treated with conditioned medium (CM) from either HCC827/PC9 cells or PCs in the presence of TKI treatment. The gene discussed is IL32; the disease is cancer.